HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL.

AbstractOBJECTIVE:
To elucidate the molecular mechanism of mutant HTRA1-dependent cerebral small vessel disease in heterozygous individuals.
METHODS:
We recruited 113 unrelated index patients with clinically diagnosed cerebral small vessel disease. The coding sequences of the HTRA1 gene were analyzed. We evaluated HTRA1 protease activities using casein assays and oligomeric HTRA1 formation using gel filtration chromatography.
RESULTS:
We found 4 heterozygous missense mutations in the HTRA1 gene (p.G283E, p.P285L, p.R302Q, and p.T319I) in 6 patients from 113 unrelated index patients and in 2 siblings in 2 unrelated families with p.R302Q. The mean age at cognitive impairment onset was 51.1 years. Spondylosis deformans was observed in all cases, whereas alopecia was observed in 3 cases; an autopsied case with p.G283E showed arteriopathy in their cerebral small arteries. These mutant HTRA1s showed markedly decreased protease activities and inhibited wild-type HTRA1 activity, whereas 2 of 3 mutant HTRA1s reported in cerebral autosomal-recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) (A252T and V297M) did not inhibit wild-type HTRA1 activity. Wild-type HTRA1 forms trimers; however, G283E and T319I HTRA1, observed in manifesting heterozygotes, did not form trimers. P285L and R302Q HTRA1s formed trimers, but their mutations were located in domains that are important for trimer-associated HTRA1 activation; in contrast, A252T and V297M HTRA1s, which have been observed in CARASIL, also formed trimers but had mutations outside the domains important for trimer-associated HTRA1 activation.
CONCLUSIONS:
The mutant HTRA1s observed in manifesting heterozygotes might result in an impaired HTRA1 activation cascade of HTRA1 or be unable to form stable trimers.
AuthorsHiroaki Nozaki, Taisuke Kato, Megumi Nihonmatsu, Yohei Saito, Ikuko Mizuta, Tomoko Noda, Ryoko Koike, Kazuhide Miyazaki, Muichi Kaito, Shoichi Ito, Masahiro Makino, Akihide Koyama, Atsushi Shiga, Masahiro Uemura, Yumi Sekine, Ayuka Murakami, Suzuko Moritani, Kenju Hara, Akio Yokoseki, Ryozo Kuwano, Naoto Endo, Takeshi Momotsu, Mari Yoshida, Masatoyo Nishizawa, Toshiki Mizuno, Osamu Onodera
JournalNeurology (Neurology) Vol. 86 Issue 21 Pg. 1964-74 (05 24 2016) ISSN: 1526-632X [Electronic] United States
PMID27164673 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2016 American Academy of Neurology.
Chemical References
  • High-Temperature Requirement A Serine Peptidase 1
  • HtrA1 protein, human
  • Serine Endopeptidases
Topics
  • Alopecia (diagnostic imaging, enzymology, genetics, pathology)
  • Brain (diagnostic imaging, enzymology, pathology)
  • Cerebral Infarction (diagnostic imaging, enzymology, genetics, pathology)
  • Chromatography, Gel
  • Dimerization
  • Family
  • Heterozygote
  • High-Temperature Requirement A Serine Peptidase 1
  • Humans
  • Leukoencephalopathies (diagnostic imaging, enzymology, genetics, pathology)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Models, Molecular
  • Mutation, Missense
  • Pedigree
  • Sequence Analysis, DNA
  • Serine Endopeptidases (genetics, metabolism)
  • Spinal Diseases (diagnostic imaging, enzymology, genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: